EPOETIN ALFA

EPOETIN ALFA was reported 11817 times

EPOETIN ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRYNS SYNDROME 13 1.0000
1 ANTI-ERYTHROPOIETIN ANTIBODY NEGATIVE 42 0.4615
2 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 93 0.3705
3 NON-NEUTRALISING ANTIBODIES POSITIVE 15 0.3659
4 PEAU D'ORANGE 26 0.2857
5 SKIN FIBROSIS 102 0.2107
6 NEPHROGENIC SYSTEMIC FIBROSIS 531 0.1755
7 DEVICE INTERACTION 39 0.1646
8 SHUNT STENOSIS 31 0.1119
9 CONGENITAL NAIL DISORDER 13 0.1066
10 SKIN INDURATION 205 0.0988
11 EXTREMITY CONTRACTURE 62 0.0969
12 JOINT CONTRACTURE 99 0.0923
13 APLASIA PURE RED CELL 274 0.0796
14 SKIN HYPERTROPHY 186 0.0661
15 NEPHROGENIC FIBROSING DERMOPATHY 13 0.0650
16 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 24 0.0632
17 ENDOMETRIAL DISORDER 24 0.0581
18 MICROTIA 17 0.0540
19 RETICULOCYTE COUNT DECREASED 23 0.0534
20 ARTERIOVENOUS FISTULA THROMBOSIS 18 0.0520
21 ARTERIOVENOUS FISTULA SITE COMPLICATION 31 0.0517
22 ARTERIOVENOUS FISTULA OCCLUSION 9 0.0514
23 REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA 10 0.0505
24 CONGESTIVE HEPATOPATHY 21 0.0469
25 FIBROSIS 136 0.0442
26 ARTERIOVENOUS FISTULA SITE HAEMORRHAGE 8 0.0428
27 CONGENITAL DIAPHRAGMATIC HERNIA 16 0.0409
28 SHUNT OCCLUSION 20 0.0394
29 HYPERPARATHYROIDISM SECONDARY 97 0.0387
30 ENTEROCOCCUS TEST POSITIVE 25 0.0386
31 INTERCEPTED PRODUCT ADMINISTRATION ERROR 283 0.0369
32 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 36 0.0339
33 BONE DEBRIDEMENT 16 0.0331
34 PSEUDOMONAL BACTERAEMIA 28 0.0328
35 SKIN TIGHTNESS 154 0.0327
36 SERUM FERRITIN ABNORMAL 10 0.0312
37 NEPHROGENIC ANAEMIA 142 0.0306
38 PERITONEAL DIALYSIS 25 0.0302
39 MARROW HYPERPLASIA 20 0.0293
40 BONE MARROW DEPRESSION 27 0.0277
41 GRAFT INFECTION 9 0.0265
42 WOUND DEBRIDEMENT 11 0.0263
43 ARTERIOVENOUS FISTULA 12 0.0244
44 SEQUESTRECTOMY 16 0.0240
45 OESOPHAGEAL ATRESIA 15 0.0240
46 BLOOD PRODUCT TRANSFUSION DEPENDENT 10 0.0238
47 TRACHEO-OESOPHAGEAL FISTULA 15 0.0235
48 HYPERPARATHYROIDISM 48 0.0233
49 NEUTRALISING ANTIBODIES POSITIVE 9 0.0216
50 RENAL FAILURE CHRONIC 160 0.0208
51 PERIPHERAL SENSORIMOTOR NEUROPATHY 25 0.0199
52 BIOPSY BONE MARROW ABNORMAL 9 0.0198
53 PULMONARY HYPOPLASIA 15 0.0190
54 CATHETER RELATED INFECTION 19 0.0188
55 MUSCLE CONTRACTURE 37 0.0182
56 RENAL TRANSPLANT 64 0.0177
57 INFECTIOUS PERITONITIS 12 0.0177
58 HAEMOGLOBIN ABNORMAL 113 0.0175
59 HYPERTENSIVE ENCEPHALOPATHY 10 0.0168
60 PRIMARY SEQUESTRUM 15 0.0166
61 BLOOD PARATHYROID HORMONE INCREASED 48 0.0165
62 CALCIPHYLAXIS 30 0.0163
63 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 542 0.0160
64 CATHETER RELATED COMPLICATION 18 0.0160
65 JUGULAR VEIN DISTENSION 9 0.0159
66 HAEMATOCRIT ABNORMAL 19 0.0154
67 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 14 0.0148
68 BLOOD PHOSPHORUS INCREASED 40 0.0146
69 COARCTATION OF THE AORTA 14 0.0145
70 NEOPLASM SKIN 22 0.0142
71 PERITONITIS BACTERIAL 141 0.0140
72 VENOUS INSUFFICIENCY 10 0.0138
73 INCORRECT PRODUCT STORAGE 181 0.0138
74 MYELOPATHY 26 0.0137
75 PRODUCT STORAGE ERROR 1124 0.0128
76 ASEPTIC NECROSIS BONE 10 0.0128
77 LEFT ATRIAL DILATATION 16 0.0125
78 VASCULAR CALCIFICATION 13 0.0122
79 HYPERPHOSPHATAEMIA 26 0.0121
80 IRON OVERLOAD 13 0.0120
81 RENAL ATROPHY 15 0.0120
82 PROCEDURAL HYPOTENSION 10 0.0118
83 JOINT RANGE OF MOTION DECREASED 152 0.0113
84 BLOOD IRON ABNORMAL 11 0.0113
85 VASCULAR ACCESS COMPLICATION 9 0.0111
86 OPEN WOUND 12 0.0107
87 HAEMODIALYSIS 89 0.0106
88 BLOOD PRESSURE DIASTOLIC ABNORMAL 26 0.0102
89 COLON ADENOMA 10 0.0101
90 END STAGE RENAL DISEASE 185 0.0101
91 NEPHROSCLEROSIS 11 0.0099
92 LIGAMENT DISORDER 9 0.0099
93 SKIN HYPERPIGMENTATION 85 0.0099
94 COMPLICATIONS OF TRANSPLANTED KIDNEY 22 0.0097
95 SERUM FERRITIN INCREASED 51 0.0097
96 NORMOCHROMIC NORMOCYTIC ANAEMIA 29 0.0096
97 KIDNEY TRANSPLANT REJECTION 45 0.0094
98 ACUTE CHEST SYNDROME 8 0.0091
99 AZOTAEMIA 36 0.0090
100 OSTEOSCLEROSIS 14 0.0089
101 ANAEMIA OF CHRONIC DISEASE 8 0.0088
102 PERITONITIS 180 0.0087
103 MULTIPLE MYELOMA 40 0.0086
104 DILATATION VENTRICULAR 18 0.0086
105 OCCULT BLOOD POSITIVE 16 0.0081
106 PERITONEAL DIALYSIS COMPLICATION 59 0.0081
107 ANAEMIA MACROCYTIC 17 0.0080
108 OSTEOLYSIS 16 0.0078
109 CLEFT PALATE 15 0.0078
110 DILATATION ATRIAL 9 0.0077
111 THERAPEUTIC RESPONSE DECREASED 458 0.0075
112 ASTERIXIS 8 0.0075
113 HYPERTENSIVE HEART DISEASE 14 0.0075
114 BLOOD IRON INCREASED 14 0.0075
115 SCAR 127 0.0074
116 DEFORMITY 69 0.0074
117 IRON DEFICIENCY 33 0.0073
118 CALCINOSIS 16 0.0072
119 LEFT VENTRICULAR HYPERTROPHY 30 0.0070
120 METABOLIC ENCEPHALOPATHY 21 0.0070
121 MICTURITION DISORDER 24 0.0069
122 FLUID OVERLOAD 100 0.0069
123 FAILURE TO THRIVE 35 0.0067
124 FUNGAL PERITONITIS 10 0.0066
125 DYSMORPHISM 15 0.0064
126 LEG AMPUTATION 26 0.0063
127 REBOUND ACID HYPERSECRETION 19 0.0063
128 KYPHOSIS 11 0.0062
129 BLOOD PARATHYROID HORMONE DECREASED 9 0.0061
130 STAPHYLOCOCCAL BACTERAEMIA 26 0.0060
131 DEVICE RELATED SEPSIS 12 0.0060
132 CARDIOMEGALY 73 0.0059
133 HAEMOGLOBIN DECREASED 607 0.0059
134 AORTIC STENOSIS 20 0.0057
135 HAEMORRHOIDAL HAEMORRHAGE 28 0.0057
136 TRANSPLANT FAILURE 14 0.0057
137 BLOOD CULTURE POSITIVE 17 0.0057
138 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 23 0.0056
139 INDURATION 10 0.0056
140 MYELODYSPLASTIC SYNDROME 81 0.0056
141 VULVOVAGINAL MYCOTIC INFECTION 22 0.0056
142 SKIN PLAQUE 47 0.0056
143 ANHEDONIA 145 0.0055
144 ESSENTIAL HYPERTENSION 10 0.0055
145 BLOOD ALBUMIN DECREASED 43 0.0054
146 LOBAR PNEUMONIA 10 0.0054
147 DIALYSIS 76 0.0054
148 GANGRENE 32 0.0053
149 ATELECTASIS 51 0.0053
150 MALNUTRITION 59 0.0053
151 HAEMORRHAGIC ANAEMIA 23 0.0052
152 CLOSTRIDIUM DIFFICILE COLITIS 55 0.0052
153 RESPIRATORY TRACT INFECTION VIRAL 12 0.0051
154 EXCORIATION 13 0.0051
155 PERIPHERAL VASCULAR DISORDER 26 0.0050
156 HAEMOGLOBIN INCREASED 23 0.0050
157 TRICUSPID VALVE INCOMPETENCE 40 0.0050
158 EXFOLIATIVE RASH 13 0.0049
159 PERIPHERAL ISCHAEMIA 20 0.0049
160 ISCHAEMIC CARDIOMYOPATHY 15 0.0049
161 BLOOD PRESSURE SYSTOLIC ABNORMAL 12 0.0049
162 POLYCYTHAEMIA 10 0.0048
163 DIVERTICULUM INTESTINAL 21 0.0048
164 RENAL TUBULAR NECROSIS 47 0.0048
165 HAEMATOCRIT DECREASED 95 0.0048
166 INTERCEPTED PRODUCT STORAGE ERROR 17 0.0048
167 OSTEITIS 12 0.0048
168 BLOOD BICARBONATE DECREASED 9 0.0047
169 HYPERKERATOSIS 26 0.0047
170 GINGIVAL RECESSION 9 0.0047
171 JOINT EFFUSION 32 0.0046
172 BLOOD POTASSIUM INCREASED 75 0.0046
173 PNEUMONIA STAPHYLOCOCCAL 9 0.0046
174 HEART DISEASE CONGENITAL 16 0.0045
175 AORTIC VALVE STENOSIS 8 0.0045
176 STAPHYLOCOCCAL SEPSIS 22 0.0045
177 GENERALISED OEDEMA 55 0.0044
178 REFUSAL OF TREATMENT BY PATIENT 29 0.0044
179 CEREBROVASCULAR DISORDER 13 0.0043
180 CACHEXIA 22 0.0043
181 TOOTH EXTRACTION 53 0.0043
182 ESCHERICHIA BACTERAEMIA 10 0.0042
183 ARTERIOSCLEROSIS CORONARY ARTERY 28 0.0042
184 PULSE ABSENT 20 0.0042
185 OSTEOMYELITIS 76 0.0042
186 DECUBITUS ULCER 34 0.0042
187 JAW FRACTURE 9 0.0042
188 MYOPATHY 36 0.0042
189 BONE LESION 15 0.0042
190 PERIODONTITIS 9 0.0042
191 OCULAR ICTERUS 18 0.0041
192 ENDOCARDITIS 21 0.0041
193 ANAEMIA 771 0.0040
194 RENAL CYST 32 0.0040
195 APLASTIC ANAEMIA 21 0.0040
196 VENTRICULAR HYPERTROPHY 10 0.0040
197 PANCYTOPENIA 222 0.0040
198 BONE MARROW DISORDER 12 0.0040
199 THROMBOSIS IN DEVICE 13 0.0040
200 HYPERLIPIDAEMIA 47 0.0039
201 BLOOD CALCIUM DECREASED 44 0.0039
202 BLOOD CHLORIDE DECREASED 10 0.0039
203 WOUND DEHISCENCE 13 0.0038
204 HYPERVOLAEMIA 19 0.0038
205 SPLENOMEGALY 45 0.0038
206 ORTHOPNOEA 12 0.0038
207 LACUNAR INFARCTION 9 0.0038
208 HYPOVOLAEMIA 22 0.0038
209 HAEMOLYSIS 29 0.0038
210 LUNG INFILTRATION 33 0.0037
211 ABDOMINAL HERNIA 17 0.0037
212 HYPERCALCAEMIA 46 0.0037
213 CAROTID ARTERY STENOSIS 13 0.0037
214 ARTERIOSCLEROSIS 35 0.0037
215 METASTATIC NEOPLASM 16 0.0037
216 BENIGN PROSTATIC HYPERPLASIA 19 0.0037
217 BONE DISORDER 67 0.0037
218 DERMAL CYST 9 0.0037
219 HEPARIN-INDUCED THROMBOCYTOPENIA 18 0.0036
220 JAW DISORDER 20 0.0036
221 HYPERKALAEMIA 128 0.0036
222 GASTRITIS EROSIVE 17 0.0036
223 MYELOFIBROSIS 11 0.0036
224 TACHYARRHYTHMIA 9 0.0036
225 CATHETER SITE HAEMORRHAGE 9 0.0036
226 JOINT STIFFNESS 94 0.0036
227 DIASTOLIC DYSFUNCTION 11 0.0036
228 PRODUCT ADMINISTRATION ERROR 72 0.0036
229 PATHOLOGICAL FRACTURE 18 0.0035
230 SPINAL OSTEOARTHRITIS 31 0.0035
231 UNRESPONSIVE TO STIMULI 91 0.0035
232 AORTIC VALVE INCOMPETENCE 15 0.0035
233 DIVERTICULUM 25 0.0035
234 ENTEROCOCCAL INFECTION 17 0.0035
235 ESCHERICHIA SEPSIS 10 0.0034
236 MITRAL VALVE INCOMPETENCE 39 0.0034
237 RALES 20 0.0034
238 ECCHYMOSIS 23 0.0034
239 RENAL FAILURE ACUTE 142 0.0033
240 BONE MARROW FAILURE 67 0.0033
241 BACTERAEMIA 39 0.0033
242 PURULENT DISCHARGE 14 0.0033
243 MENTAL STATUS CHANGES 91 0.0033
244 RENAL INJURY 97 0.0033
245 CEREBRAL ATROPHY 13 0.0033
246 CLOSTRIDIAL INFECTION 11 0.0032
247 TRANSFUSION 34 0.0032
248 LOCALISED OEDEMA 15 0.0032
249 MULTI-ORGAN FAILURE 56 0.0032
250 HYPOCALCAEMIA 61 0.0032
251 NEPHROPATHY 30 0.0032
252 BRONCHOPNEUMONIA 11 0.0032
253 BLOOD CREATININE ABNORMAL 11 0.0032
254 BLOOD UREA INCREASED 53 0.0032
255 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 16 0.0032
256 GINGIVITIS 17 0.0031
257 RENAL FAILURE 416 0.0031
258 CARDIAC MURMUR 27 0.0031
259 VENTRICULAR HYPOKINESIA 10 0.0031
260 AORTIC ARTERIOSCLEROSIS 8 0.0031
261 ABSCESS 49 0.0031
262 VENOUS THROMBOSIS 12 0.0031
263 EMBOLISM VENOUS 9 0.0030
264 SUPRAVENTRICULAR EXTRASYSTOLES 10 0.0030
265 CARDIO-RESPIRATORY ARREST 123 0.0029
266 OEDEMA PERIPHERAL 358 0.0029
267 ASCITES 86 0.0029
268 NERVE COMPRESSION 27 0.0029
269 WHEELCHAIR USER 13 0.0029
270 ARTHRITIS BACTERIAL 12 0.0029
271 CEREBRAL ISCHAEMIA 15 0.0029
272 ABASIA 72 0.0029
273 PLEURAL EFFUSION 177 0.0029
274 MYOCARDIAL ISCHAEMIA 33 0.0029
275 PYELONEPHRITIS 25 0.0029
276 ACIDOSIS 22 0.0029
277 SEPSIS 317 0.0028
278 LEFT VENTRICULAR DYSFUNCTION 19 0.0028
279 BONE EROSION 10 0.0028
280 CARDIAC FAILURE CHRONIC 12 0.0028
281 LUNG NEOPLASM 12 0.0028
282 HYDRONEPHROSIS 21 0.0028
283 LOOSE TOOTH 9 0.0028
284 ANGINA UNSTABLE 18 0.0028
285 HAEMORRHOIDS 54 0.0028
286 SCLERODERMA 10 0.0027
287 MOTOR DYSFUNCTION 28 0.0027
288 CANDIDIASIS 11 0.0027
289 PEPTIC ULCER 9 0.0027
290 CHRONIC KIDNEY DISEASE 205 0.0027
291 RETINOPATHY 10 0.0027
292 HAEMOLYTIC ANAEMIA 24 0.0027
293 PROTEIN TOTAL DECREASED 10 0.0027
294 DIABETIC RETINOPATHY 9 0.0026
295 SUDDEN CARDIAC DEATH 9 0.0026
296 BREATH SOUNDS ABNORMAL 13 0.0026
297 NO THERAPEUTIC RESPONSE 32 0.0026
298 SUPRAVENTRICULAR TACHYCARDIA 25 0.0026
299 QUALITY OF LIFE DECREASED 35 0.0026
300 SKIN ATROPHY 15 0.0026
301 DEVICE RELATED INFECTION 40 0.0026
302 SKIN DISCOLOURATION 119 0.0026
303 BLOOD CREATININE INCREASED 169 0.0026
304 SEPTIC SHOCK 112 0.0026
305 PSEUDOMONAS INFECTION 22 0.0026
306 MOBILITY DECREASED 184 0.0026
307 CARDIAC FAILURE CONGESTIVE 204 0.0025
308 BLOOD IRON DECREASED 30 0.0025
309 IMMOBILE 11 0.0025
310 SKIN ULCER 65 0.0025
311 TRANSPLANT REJECTION 20 0.0025
312 BLOOD PRESSURE SYSTOLIC INCREASED 48 0.0025
313 THROMBOCYTOSIS 9 0.0025
314 OEDEMA 133 0.0024
315 PIGMENTATION DISORDER 15 0.0024
316 INJURY 170 0.0024
317 ACUTE CORONARY SYNDROME 20 0.0024
318 PULMONARY OEDEMA 108 0.0024
319 ANOREXIA 31 0.0024
320 PULMONARY HYPERTENSION 50 0.0024
321 PULSELESS ELECTRICAL ACTIVITY 10 0.0024
322 ADRENAL INSUFFICIENCY 29 0.0024
323 IRON DEFICIENCY ANAEMIA 22 0.0024
324 SKIN LESION 65 0.0024
325 STAPHYLOCOCCAL INFECTION 78 0.0024
326 PULMONARY CONGESTION 31 0.0023
327 VENTRICULAR FIBRILLATION 26 0.0023
328 COAGULOPATHY 39 0.0023
329 BLOOD ALKALINE PHOSPHATASE INCREASED 58 0.0023
330 NECROSIS 13 0.0023
331 SPINAL COLUMN STENOSIS 11 0.0023
332 LEUKOCYTOSIS 42 0.0023
333 SKIN NECROSIS 12 0.0023
334 ECONOMIC PROBLEM 35 0.0023
335 CARDIOPULMONARY FAILURE 9 0.0023
336 LARGE INTESTINE PERFORATION 16 0.0023
337 MEDICAL DEVICE COMPLICATION 17 0.0023
338 CYANOSIS 36 0.0023
339 OSTEONECROSIS 75 0.0023
340 HYPOTENSION 458 0.0023
341 RESPIRATORY DISTRESS 63 0.0023
342 ACUTE MYOCARDIAL INFARCTION 67 0.0023
343 THROMBOCYTOPENIA 253 0.0023
344 PHYSICAL DISABILITY 10 0.0023
345 RETINAL HAEMORRHAGE 16 0.0022
346 SKIN PAPILLOMA 9 0.0022
347 ELECTROLYTE IMBALANCE 26 0.0022
348 FISTULA 25 0.0022
349 PROCEDURAL COMPLICATION 17 0.0022
350 INTESTINAL ISCHAEMIA 12 0.0022
351 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
352 PROTHROMBIN TIME PROLONGED 13 0.0022
353 TOXIC ENCEPHALOPATHY 11 0.0022
354 EMBOLISM 18 0.0022
355 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
356 HYPOMAGNESAEMIA 30 0.0022
357 PRODUCT TEMPERATURE EXCURSION ISSUE 11 0.0021
358 UMBILICAL HERNIA 10 0.0021
359 ACUTE RESPIRATORY FAILURE 41 0.0021
360 CELLULITIS 107 0.0021
361 ESCHERICHIA URINARY TRACT INFECTION 9 0.0021
362 OSTEOPENIA 32 0.0021
363 PETECHIAE 22 0.0021
364 INJECTION SITE EXTRAVASATION 26 0.0021
365 CARDIAC FAILURE ACUTE 14 0.0021
366 MUSCLE TIGHTNESS 34 0.0021
367 DIVERTICULITIS 58 0.0021
368 ANURIA 18 0.0021
369 CARDIAC ARREST 172 0.0021
370 PELVIC FRACTURE 16 0.0021
371 MUSCLE ATROPHY 26 0.0021
372 GASTROINTESTINAL HAEMORRHAGE 171 0.0020
373 GINGIVAL SWELLING 9 0.0020
374 PURPURA 18 0.0020
375 ILEUS PARALYTIC 9 0.0020
376 BLOOD PRESSURE INADEQUATELY CONTROLLED 12 0.0020
377 PERICARDIAL EFFUSION 46 0.0020
378 CORONARY ARTERY STENOSIS 10 0.0020
379 CORONARY ARTERY DISEASE 60 0.0020
380 HYPOGLYCAEMIA 96 0.0020
381 KLEBSIELLA INFECTION 10 0.0020
382 SINUS TACHYCARDIA 28 0.0020
383 GENERAL PHYSICAL HEALTH DETERIORATION 228 0.0020
384 CARDIAC FAILURE 158 0.0020
385 CARDIOMYOPATHY 29 0.0020
386 RESPIRATORY ARREST 54 0.0020
387 ISCHAEMIA 9 0.0020
388 UROSEPSIS 18 0.0019
389 SKIN DISORDER 65 0.0019
390 PERONEAL NERVE PALSY 11 0.0019
391 STOMACH DISCOMFORT 10 0.0019
392 HIATUS HERNIA 25 0.0019
393 NEUROLOGICAL SYMPTOM 11 0.0019
394 ENCEPHALOPATHY 47 0.0019
395 MULTIPLE INJURIES 12 0.0019
396 CHRONIC LYMPHOCYTIC LEUKAEMIA 9 0.0019
397 LOWER GASTROINTESTINAL HAEMORRHAGE 14 0.0019
398 RED BLOOD CELL COUNT DECREASED 54 0.0019
399 ATRIAL FLUTTER 15 0.0019
400 RASH PAPULAR 42 0.0019
401 VITAMIN D DECREASED 16 0.0019
402 COMPRESSION FRACTURE 10 0.0019
403 SENSORY LOSS 15 0.0019
404 DEEP VEIN THROMBOSIS 121 0.0019
405 CONVULSION 106 0.0019
406 BLOOD BILIRUBIN INCREASED 50 0.0018
407 ILEUS 23 0.0018
408 GASTROENTERITIS 27 0.0018
409 PRURITUS GENERALISED 40 0.0018
410 DISSEMINATED INTRAVASCULAR COAGULATION 26 0.0018
411 URINE OUTPUT DECREASED 16 0.0018
412 INTERVERTEBRAL DISC PROTRUSION 40 0.0018
413 ESCHERICHIA INFECTION 15 0.0018
414 HYPOKALAEMIA 84 0.0018
415 DIABETIC NEUROPATHY 9 0.0018
416 RESPIRATORY FAILURE 132 0.0018
417 FOETAL GROWTH RESTRICTION 11 0.0018
418 DENTAL CARIES 20 0.0018
419 GASTRIC ULCER HAEMORRHAGE 10 0.0018
420 DERMATITIS EXFOLIATIVE 9 0.0018
421 GASTRITIS 47 0.0018
422 ACUTE PULMONARY OEDEMA 10 0.0018
423 ATRIAL FIBRILLATION 173 0.0018
424 ULCER HAEMORRHAGE 12 0.0018
425 TOOTH ABSCESS 18 0.0018
426 PLATELET COUNT INCREASED 23 0.0018
427 BLOOD SODIUM DECREASED 33 0.0017
428 NEPHROTIC SYNDROME 12 0.0017
429 RENAL IMPAIRMENT 147 0.0017
430 CARDIAC VALVE DISEASE 10 0.0017
431 OSTEONECROSIS OF JAW 43 0.0017
432 EJECTION FRACTION DECREASED 27 0.0017
433 GRAND MAL CONVULSION 16 0.0017
434 HEPATOMEGALY 17 0.0017
435 DYSPNOEA EXERTIONAL 65 0.0017
436 HYPOXIA 60 0.0017
437 PLATELET COUNT DECREASED 181 0.0017
438 PAIN IN JAW 48 0.0017
439 SPINAL COMPRESSION FRACTURE 14 0.0017
440 THERAPY NON-RESPONDER 76 0.0017
441 FOOD POISONING 9 0.0017
442 SLEEP APNOEA SYNDROME 32 0.0017
443 HYPOALBUMINAEMIA 13 0.0017
444 PAIN OF SKIN 45 0.0017
445 WALKING AID USER 11 0.0017
446 SKIN MASS 11 0.0016
447 PNEUMONIA ASPIRATION 41 0.0016
448 VENTRICULAR EXTRASYSTOLES 17 0.0016
449 GINGIVAL PAIN 13 0.0016
450 TENDERNESS 17 0.0016
451 COLITIS ISCHAEMIC 11 0.0016
452 POSTOPERATIVE WOUND INFECTION 11 0.0016
453 METABOLIC ACIDOSIS 52 0.0016
454 HYPOPHOSPHATAEMIA 12 0.0016
455 GENERAL PHYSICAL CONDITION ABNORMAL 11 0.0016
456 ANGIOPATHY 9 0.0016
457 BONE PAIN 94 0.0016
458 BLOOD CALCIUM INCREASED 14 0.0016
459 LARGE INTESTINE POLYP 11 0.0016
460 EMPHYSEMA 16 0.0016
461 IMPAIRED HEALING 52 0.0016
462 OSTEOARTHRITIS 67 0.0016
463 VENTRICULAR TACHYCARDIA 26 0.0016
464 SUBARACHNOID HAEMORRHAGE 16 0.0016
465 EMOTIONAL DISTRESS 190 0.0016
466 MEDICATION ERROR 87 0.0016
467 BLOOD POTASSIUM DECREASED 47 0.0016
468 SINUS BRADYCARDIA 15 0.0016
469 TOOTHACHE 28 0.0015
470 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
471 INTERNATIONAL NORMALISED RATIO INCREASED 44 0.0015
472 TRANSIENT ISCHAEMIC ATTACK 52 0.0015
473 FEBRILE NEUTROPENIA 102 0.0015
474 SUBDURAL HAEMATOMA 22 0.0015
475 EXOSTOSIS 14 0.0015
476 HYPERTENSIVE CRISIS 17 0.0015
477 HYPOGAMMAGLOBULINAEMIA 10 0.0015
478 BLOOD COUNT ABNORMAL 23 0.0015
479 SUDDEN DEATH 16 0.0015
480 WHITE BLOOD CELL COUNT INCREASED 58 0.0015
481 LOW BIRTH WEIGHT BABY 12 0.0015
482 HYPERTENSION 319 0.0015
483 ANGINA PECTORIS 43 0.0015
484 SKIN SWELLING 13 0.0015
485 BLINDNESS TRANSIENT 11 0.0015
486 SQUAMOUS CELL CARCINOMA OF SKIN 9 0.0015
487 NEOPLASM 17 0.0015
488 CYTOPENIA 18 0.0015
489 DRUG TOXICITY 20 0.0015
490 HYPERAESTHESIA 12 0.0015
491 VASCULITIS 17 0.0015
492 SCOLIOSIS 9 0.0015
493 BACTERIAL INFECTION 27 0.0014
494 LETHARGY 83 0.0014
495 LEUKOPENIA 72 0.0014
496 ATRIAL SEPTAL DEFECT 12 0.0014
497 MASS 20 0.0014
498 MUSCULOSKELETAL STIFFNESS 125 0.0014
499 HAEMORRHAGIC STROKE 11 0.0014
500 POST PROCEDURAL COMPLICATION 27 0.0014
501 ABDOMINAL PAIN 326 0.0014
502 RENAL DISORDER 65 0.0014
503 HEPATIC ENCEPHALOPATHY 13 0.0014
504 ACUTE KIDNEY INJURY 213 0.0014
505 HERPES SIMPLEX 9 0.0014
506 TENDON DISORDER 9 0.0014
507 ORTHOSTATIC HYPOTENSION 24 0.0014
508 OESOPHAGITIS 15 0.0014
509 HAEMATURIA 47 0.0014
510 HIP FRACTURE 44 0.0014
511 NEUROPATHY PERIPHERAL 130 0.0014
512 CHEST PAIN 253 0.0014
513 FACE OEDEMA 23 0.0014
514 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 13 0.0014
515 PULMONARY FIBROSIS 26 0.0014
516 BLOOD PRESSURE DECREASED 90 0.0014
517 RESPIRATORY RATE INCREASED 12 0.0014
518 TOOTH DISORDER 30 0.0013
519 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
520 BRADYCARDIA 71 0.0013
521 NEPHROPATHY TOXIC 15 0.0013
522 TUBULOINTERSTITIAL NEPHRITIS 25 0.0013
523 PLASMA CELL MYELOMA 52 0.0013
524 BLOOD LACTATE DEHYDROGENASE INCREASED 21 0.0013
525 IMPAIRED GASTRIC EMPTYING 18 0.0013
526 MELAENA 29 0.0013
527 SCAB 15 0.0013
528 PROTEINURIA 25 0.0013
529 AORTIC ANEURYSM 10 0.0013
530 DISORIENTATION 52 0.0013
531 GAMMA-GLUTAMYLTRANSFERASE INCREASED 29 0.0013
532 ASTHENIA 492 0.0013
533 INCREASED APPETITE 25 0.0013
534 SMALL INTESTINAL OBSTRUCTION 16 0.0013
535 EPISTAXIS 97 0.0013
536 ATRIOVENTRICULAR BLOCK 10 0.0013
537 CONGENITAL ANOMALY 10 0.0013
538 HAEMOPTYSIS 36 0.0013
539 ACUTE MYELOID LEUKAEMIA 20 0.0013
540 NEUTROPENIA 174 0.0013
541 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
542 DEHYDRATION 170 0.0013
543 PULMONARY TOXICITY 9 0.0013
544 HERPES ZOSTER 73 0.0013
545 PNEUMONIA 410 0.0013
546 HYPERGLYCAEMIA 46 0.0013
547 MYOCLONUS 15 0.0013
548 BLOOD PRESSURE ABNORMAL 25 0.0013
549 CARDIOGENIC SHOCK 18 0.0013
550 CEREBROVASCULAR ACCIDENT 212 0.0013
551 ORAL PAIN 28 0.0012
552 TACHYPNOEA 17 0.0012
553 HEPATITIS C 15 0.0012
554 RECTAL HAEMORRHAGE 53 0.0012
555 VITAMIN D DEFICIENCY 12 0.0012
556 INCONTINENCE 13 0.0012
557 RESPIRATORY TRACT INFECTION 32 0.0012
558 SHOCK HAEMORRHAGIC 10 0.0012
559 GOUT 22 0.0012
560 MUSCULAR WEAKNESS 139 0.0012
561 RIB FRACTURE 25 0.0012
562 ACTIVITIES OF DAILY LIVING IMPAIRED 24 0.0012
563 BLOOD PRESSURE INCREASED 185 0.0012
564 PULMONARY MASS 18 0.0012
565 BLOOD PRESSURE FLUCTUATION 29 0.0012
566 DECREASED ACTIVITY 13 0.0012
567 LOCAL SWELLING 21 0.0012
568 HAEMORRHAGE INTRACRANIAL 18 0.0012
569 RASH GENERALISED 31 0.0012
570 HEPATIC FAILURE 36 0.0012
571 FLANK PAIN 11 0.0012
572 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 61 0.0012
573 ROTATOR CUFF SYNDROME 15 0.0012
574 CORONARY ARTERY OCCLUSION 16 0.0012
575 LEUKAEMIA 11 0.0012
576 SPINAL DISORDER 11 0.0012
577 HAEMATOTOXICITY 11 0.0012
578 HYPOAESTHESIA 173 0.0012
579 COORDINATION ABNORMAL 16 0.0011
580 VOMITING 538 0.0011
581 CYTOMEGALOVIRUS INFECTION 19 0.0011
582 ORAL CANDIDIASIS 15 0.0011
583 IMMUNOSUPPRESSION 10 0.0011
584 SHOCK 26 0.0011
585 PREMATURE DELIVERY 18 0.0011
586 OBESITY 18 0.0011
587 CHOLELITHIASIS 37 0.0011
588 ANXIETY 320 0.0011
589 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
590 HAEMATOMA 29 0.0011
591 POST PROCEDURAL HAEMORRHAGE 13 0.0011
592 DYSPNOEA 632 0.0011
593 FEAR 30 0.0011
594 MYOSITIS 10 0.0011
595 WOUND 31 0.0011
596 HOSPITALISATION 170 0.0011
597 GASTRIC ULCER 21 0.0011
598 SKIN EXFOLIATION 93 0.0011
599 SYNCOPE 110 0.0011
600 POLYURIA 9 0.0011
601 ARRHYTHMIA 52 0.0011
602 METASTASES TO BONE 18 0.0011
603 WOUND INFECTION 12 0.0011
604 CHOLECYSTITIS 13 0.0011
605 PNEUMONIA BACTERIAL 10 0.0011
606 TOOTH FRACTURE 12 0.0011
607 PYREXIA 376 0.0011
608 SECOND PRIMARY MALIGNANCY 9 0.0011
609 TACHYCARDIA 96 0.0011
610 RETCHING 23 0.0011
611 PNEUMOTHORAX 17 0.0011
612 SKIN INFECTION 12 0.0011
613 THIRST 19 0.0011
614 LACERATION 10 0.0011
615 SQUAMOUS CELL CARCINOMA 10 0.0011
616 LYMPHOPENIA 15 0.0011
617 LYMPHADENOPATHY 37 0.0010
618 UNEVALUABLE EVENT 79 0.0010
619 UPPER RESPIRATORY TRACT INFECTION 48 0.0010
620 HYPERCHOLESTEROLAEMIA 10 0.0010
621 MUCOSAL INFLAMMATION 27 0.0010
622 THROMBOTIC MICROANGIOPATHY 10 0.0010
623 URINARY TRACT INFECTION 175 0.0010
624 HAEMATEMESIS 26 0.0010
625 CARDIOVASCULAR DISORDER 26 0.0010
626 METASTASES TO LIVER 18 0.0010
627 CEREBRAL INFARCTION 25 0.0010
628 HYPERSENSITIVITY 189 0.0010
629 FAECES DISCOLOURED 22 0.0010
630 COLON CANCER 15 0.0010
631 RASH MACULAR 35 0.0010
632 MYOCARDIAL INFARCTION 174 0.0010
633 HYPOAESTHESIA ORAL 15 0.0010
634 BEDRIDDEN 13 0.0010
635 DYSURIA 36 0.0010
636 MUSCULOSKELETAL PAIN 51 0.0010
637 DYSPHAGIA 92 0.0010
638 WHITE BLOOD CELL COUNT DECREASED 105 0.0010
639 CYST 12 0.0010
640 THROAT TIGHTNESS 26 0.0010
641 GINGIVAL BLEEDING 13 0.0010
642 CAESAREAN SECTION 11 0.0009
643 HAEMATOCHEZIA 52 0.0009
644 CATARACT 56 0.0009
645 HEART RATE INCREASED 93 0.0009
646 DEPRESSED LEVEL OF CONSCIOUSNESS 37 0.0009
647 GAIT DISTURBANCE 179 0.0009
648 TREATMENT NONCOMPLIANCE 51 0.0009
649 BODY TEMPERATURE INCREASED 19 0.0009
650 METASTASES TO CENTRAL NERVOUS SYSTEM 12 0.0009
651 MUSCULOSKELETAL DISCOMFORT 16 0.0009
652 CARPAL TUNNEL SYNDROME 13 0.0009
653 DELIRIUM 32 0.0009
654 SKIN FISSURES 18 0.0009
655 CLOSTRIDIUM DIFFICILE INFECTION 20 0.0009
656 HAND DEFORMITY 12 0.0009
657 ASPIRATION 10 0.0009
658 PHARYNGEAL OEDEMA 14 0.0009
659 PAIN 559 0.0009
660 CONFUSIONAL STATE 147 0.0009
661 HYPOTHYROIDISM 29 0.0009
662 BURSITIS 11 0.0009
663 NOCTURIA 11 0.0009
664 CHILLS 106 0.0009
665 DYSARTHRIA 34 0.0009
666 HYPOPHAGIA 23 0.0009
667 BRAIN INJURY 9 0.0009
668 LOSS OF CONSCIOUSNESS 115 0.0009
669 PREMATURE BABY 27 0.0009
670 BRONCHITIS 66 0.0009
671 SICKLE CELL ANAEMIA WITH CRISIS 14 0.0009
672 SYNOVITIS 16 0.0009
673 RESTLESS LEGS SYNDROME 16 0.0009
674 INFECTION 127 0.0009
675 PAIN IN EXTREMITY 258 0.0009
676 CHOLECYSTECTOMY 10 0.0009
677 OSTEOPOROSIS 36 0.0009
678 PERIPHERAL COLDNESS 12 0.0009
679 PULMONARY EMBOLISM 83 0.0009
680 CEREBRAL HAEMORRHAGE 31 0.0009
681 TYPE 2 DIABETES MELLITUS 29 0.0009
682 COMA 41 0.0009
683 HAEMORRHAGE 90 0.0009
684 INFUSION RELATED REACTION 57 0.0009
685 DIARRHOEA 555 0.0009
686 DERMATITIS 18 0.0009
687 DRUG RESISTANCE 22 0.0009
688 EOSINOPHILIA 15 0.0009
689 OXYGEN SATURATION DECREASED 48 0.0009
690 CONSTIPATION 186 0.0009
691 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
692 LIMB INJURY 23 0.0008
693 PALLOR 23 0.0008
694 VIRAL INFECTION 28 0.0008
695 LYMPHOMA 13 0.0008
696 GALLBLADDER DISORDER 15 0.0008
697 POLYNEUROPATHY 10 0.0008
698 BASAL CELL CARCINOMA 13 0.0008
699 HYPERTHYROIDISM 12 0.0008
700 BURNING SENSATION 58 0.0008
701 LOCALISED INFECTION 20 0.0008
702 HEMIPARESIS 14 0.0008
703 EYE HAEMORRHAGE 11 0.0008
704 CIRCULATORY COLLAPSE 14 0.0008
705 DYSSTASIA 24 0.0008
706 GASTROOESOPHAGEAL REFLUX DISEASE 66 0.0008
707 ULCER 13 0.0008
708 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
709 SENSORY DISTURBANCE 13 0.0008
710 INTESTINAL PERFORATION 9 0.0008
711 PRURITUS 308 0.0008
712 CONTUSION 77 0.0008
713 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
714 HEART RATE DECREASED 28 0.0008
715 HEART RATE IRREGULAR 18 0.0008
716 ANAPHYLACTIC REACTION 44 0.0008
717 DEPRESSION 181 0.0008
718 FULL BLOOD COUNT DECREASED 16 0.0008
719 DECREASED APPETITE 184 0.0008
720 TASTE DISORDER 16 0.0008
721 MICTURITION URGENCY 9 0.0008
722 ALTERED STATE OF CONSCIOUSNESS 17 0.0008
723 ALANINE AMINOTRANSFERASE INCREASED 48 0.0008
724 NEOPLASM PROGRESSION 27 0.0008
725 MUSCULOSKELETAL CHEST PAIN 12 0.0008
726 RASH ERYTHEMATOUS 37 0.0008
727 FLUID RETENTION 39 0.0008
728 HYPONATRAEMIA 43 0.0008
729 SYSTEMIC LUPUS ERYTHEMATOSUS 27 0.0008
730 NAUSEA 601 0.0008
731 TOOTH INFECTION 10 0.0008
732 ATAXIA 9 0.0008
733 RASH PRURITIC 41 0.0008
734 LIVER FUNCTION TEST ABNORMAL 22 0.0008
735 CONJUNCTIVITIS 14 0.0008
736 JOINT SWELLING 91 0.0008
737 MUSCLE RIGIDITY 9 0.0008
738 CHEST DISCOMFORT 77 0.0008
739 WEIGHT DECREASED 209 0.0007
740 BLISTER 42 0.0007
741 LABORATORY TEST ABNORMAL 22 0.0007
742 WHEEZING 44 0.0007
743 SWOLLEN TONGUE 23 0.0007
744 BLINDNESS 30 0.0007
745 BACK INJURY 8 0.0007
746 DIABETES MELLITUS 56 0.0007
747 PNEUMONITIS 20 0.0007
748 GLAUCOMA 14 0.0007
749 TOOTH LOSS 15 0.0007
750 EAR PAIN 14 0.0007
751 STEVENS-JOHNSON SYNDROME 16 0.0007
752 PANCREATITIS 38 0.0007
753 FALL 238 0.0007
754 PERICARDITIS 12 0.0007
755 KIDNEY INFECTION 14 0.0007
756 MOUTH ULCERATION 15 0.0007
757 RESTLESSNESS 26 0.0007
758 CARDIAC DISORDER 66 0.0007
759 THERAPY PARTIAL RESPONDER 11 0.0007
760 HEPATITIS 18 0.0007
761 DISEASE PROGRESSION 83 0.0007
762 PRESYNCOPE 17 0.0007
763 THROMBOSIS 56 0.0007
764 ELECTROCARDIOGRAM QT PROLONGED 25 0.0007
765 GASTROINTESTINAL DISORDER 62 0.0007
766 NODULE 9 0.0007
767 HYPOKINESIA 10 0.0007
768 BLOOD GLUCOSE DECREASED 33 0.0007
769 HYPERHIDROSIS 88 0.0007
770 NIGHT SWEATS 22 0.0007
771 ABDOMINAL DISTENSION 71 0.0007
772 ADVERSE REACTION 9 0.0007
773 INFLAMMATION 35 0.0007
774 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19 0.0007
775 RESPIRATORY DISORDER 20 0.0007
776 BACK PAIN 155 0.0007
777 VISUAL ACUITY REDUCED 22 0.0007
778 APHASIA 20 0.0007
779 DRY SKIN 88 0.0007
780 DRUG DISPENSING ERROR 10 0.0007
781 MALIGNANT NEOPLASM PROGRESSION 67 0.0007
782 FEELING HOT 40 0.0007
783 ERYTHEMA 134 0.0007
784 SWELLING 61 0.0007
785 SPEECH DISORDER 34 0.0006
786 CYTOKINE RELEASE SYNDROME 13 0.0006
787 RHABDOMYOLYSIS 27 0.0006
788 FEELING COLD 18 0.0006
789 LUNG INFECTION 10 0.0006
790 BLOOD URINE PRESENT 12 0.0006
791 URINARY RETENTION 21 0.0006
792 NEOPLASM MALIGNANT 42 0.0006
793 PARAESTHESIA 99 0.0006
794 LOWER LIMB FRACTURE 12 0.0006
795 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
796 HERNIA 12 0.0006
797 ISCHAEMIC STROKE 11 0.0006
798 DEATH 525 0.0006
799 GASTROENTERITIS VIRAL 11 0.0006
800 DISABILITY 12 0.0006
801 UPPER LIMB FRACTURE 12 0.0006
802 FUNGAL INFECTION 20 0.0006
803 COUGH 168 0.0006
804 PRODUCT DISPENSING ERROR 13 0.0006
805 OFF LABEL USE 522 0.0006
806 RASH 259 0.0006
807 ABDOMINAL PAIN LOWER 15 0.0006
808 ARTHRALGIA 245 0.0006
809 HEPATIC CIRRHOSIS 11 0.0006
810 RASH MACULO-PAPULAR 13 0.0006
811 ASPARTATE AMINOTRANSFERASE INCREASED 31 0.0006
812 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
813 ABDOMINAL PAIN UPPER 120 0.0006
814 TENDONITIS 9 0.0006
815 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 17 0.0006
816 COLITIS 22 0.0006
817 VERTIGO 35 0.0006
818 URINARY INCONTINENCE 17 0.0006
819 NEUROTOXICITY 10 0.0006
820 COLD SWEAT 10 0.0006
821 CYSTITIS 18 0.0006
822 FATIGUE 435 0.0006
823 INTERSTITIAL LUNG DISEASE 27 0.0006
824 MUSCLE SPASMS 101 0.0005
825 LIMB DISCOMFORT 17 0.0005
826 INFLUENZA 61 0.0005
827 DIZZINESS 272 0.0005
828 PERIPHERAL SWELLING 84 0.0005
829 ERECTILE DYSFUNCTION 14 0.0005
830 LIVER DISORDER 24 0.0005
831 DISCOMFORT 33 0.0005
832 PHARMACEUTICAL PRODUCT COMPLAINT 14 0.0005
833 HEPATOTOXICITY 12 0.0005
834 DRUG EFFECT DECREASED 29 0.0005
835 SWELLING FACE 35 0.0005
836 DRUG INTERACTION 85 0.0005
837 PANCREATITIS ACUTE 12 0.0005
838 INTESTINAL OBSTRUCTION 20 0.0005
839 PALPITATIONS 62 0.0005
840 FRACTURE 10 0.0005
841 FOOT FRACTURE 10 0.0005
842 JAUNDICE 14 0.0005
843 DYSKINESIA 21 0.0005
844 JOINT INJURY 11 0.0005
845 SURGERY 30 0.0005
846 STOMATITIS 31 0.0005
847 LYMPHOCYTE COUNT DECREASED 9 0.0005
848 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 103 0.0005
849 MALAISE 222 0.0005
850 MYALGIA 86 0.0005
851 MENTAL DISORDER 22 0.0005
852 PROCEDURAL PAIN 14 0.0005
853 NEUTROPHIL COUNT DECREASED 20 0.0005
854 AGITATION 36 0.0005
855 DYSPEPSIA 48 0.0005
856 ARTHROPATHY 27 0.0005
857 GYNAECOMASTIA 15 0.0005
858 DYSGEUSIA 36 0.0005
859 AGRANULOCYTOSIS 9 0.0005
860 HEPATIC STEATOSIS 9 0.0005
861 NERVOUS SYSTEM DISORDER 15 0.0005
862 ADVERSE EVENT 44 0.0005
863 MUSCLE TWITCHING 11 0.0005
864 HEAD INJURY 15 0.0005
865 HALLUCINATION, VISUAL 10 0.0005
866 MUSCULOSKELETAL DISORDER 9 0.0005
867 FLUSHING 48 0.0005
868 C-REACTIVE PROTEIN INCREASED 17 0.0005
869 TREMOR 77 0.0005
870 DIPLOPIA 12 0.0005
871 MATERNAL EXPOSURE DURING PREGNANCY 41 0.0005
872 NEPHROLITHIASIS 21 0.0005
873 SINUS DISORDER 9 0.0005
874 NEURALGIA 11 0.0005
875 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
876 INSOMNIA 118 0.0004
877 EXTRAPYRAMIDAL DISORDER 11 0.0004
878 DISEASE RECURRENCE 21 0.0004
879 BALANCE DISORDER 38 0.0004
880 NASOPHARYNGITIS 80 0.0004
881 ROAD TRAFFIC ACCIDENT 18 0.0004
882 EYE SWELLING 16 0.0004
883 CONDITION AGGRAVATED 130 0.0004
884 EMOTIONAL DISORDER 13 0.0004
885 FEMUR FRACTURE 13 0.0004
886 PRODUCTIVE COUGH 20 0.0004
887 WRONG TECHNIQUE IN DRUG USAGE PROCESS 15 0.0004
888 NECK PAIN 23 0.0004
889 ABDOMINAL DISCOMFORT 69 0.0004
890 DYSPHONIA 24 0.0004
891 FEELING ABNORMAL 98 0.0004
892 LUNG DISORDER 20 0.0004
893 ARTHRITIS 32 0.0004
894 HEPATIC FUNCTION ABNORMAL 15 0.0004
895 CHROMATURIA 9 0.0004
896 SEIZURE 46 0.0004
897 HALLUCINATION 30 0.0004
898 BLOOD GLUCOSE INCREASED 75 0.0004
899 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
900 HEADACHE 248 0.0004
901 SOMNOLENCE 79 0.0004
902 INCORRECT ROUTE OF DRUG ADMINISTRATION 14 0.0004
903 ADVERSE DRUG REACTION 35 0.0004
904 RHINORRHOEA 25 0.0004
905 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
906 DRUG EFFECT INCOMPLETE 14 0.0004
907 WEIGHT INCREASED 86 0.0004
908 POLLAKIURIA 16 0.0004
909 DEAFNESS 10 0.0004
910 SEDATION 10 0.0004
911 SINUSITIS 39 0.0004
912 NASAL CONGESTION 22 0.0004
913 LACTIC ACIDOSIS 12 0.0004
914 DEMENTIA 10 0.0004
915 VISION BLURRED 49 0.0004
916 ABNORMAL BEHAVIOUR 14 0.0004
917 DRUG EXPOSURE DURING PREGNANCY 12 0.0004
918 URTICARIA 59 0.0004
919 HEPATIC ENZYME INCREASED 24 0.0004
920 MOVEMENT DISORDER 11 0.0003
921 LUNG NEOPLASM MALIGNANT 14 0.0003
922 VISUAL IMPAIRMENT 42 0.0003
923 IRRITABILITY 20 0.0003
924 FOETAL EXPOSURE DURING PREGNANCY 27 0.0003
925 THERAPY CESSATION 17 0.0003
926 LACRIMATION INCREASED 10 0.0003
927 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
928 RHEUMATOID ARTHRITIS 37 0.0003
929 OROPHARYNGEAL PAIN 30 0.0003
930 TARDIVE DYSKINESIA 9 0.0003
931 HYPERSOMNIA 9 0.0003
932 ALOPECIA 60 0.0003
933 EYE DISORDER 10 0.0003
934 ACCIDENTAL OVERDOSE 11 0.0003
935 FLATULENCE 17 0.0003
936 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
937 DRY MOUTH 24 0.0003
938 DRUG ADMINISTRATION ERROR 9 0.0003
939 INFLUENZA LIKE ILLNESS 24 0.0003
940 GASTRIC DISORDER 10 0.0003
941 COVID-19 51 0.0003
942 DRUG DOSE OMISSION 48 0.0003
943 EXPOSURE DURING PREGNANCY 18 0.0003
944 BONE DENSITY DECREASED 9 0.0003
945 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
946 DRUG INEFFECTIVE 376 0.0003
947 ILL-DEFINED DISORDER 17 0.0003
948 HYPOACUSIS 12 0.0003
949 AMNESIA 18 0.0003
950 VAGINAL HAEMORRHAGE 12 0.0003
951 LIP SWELLING 9 0.0003
952 THROAT IRRITATION 12 0.0003
953 BLOOD CHOLESTEROL INCREASED 12 0.0003
954 ASTHMA 29 0.0003
955 SLEEP DISORDER 18 0.0003
956 THERAPY INTERRUPTED 18 0.0003
957 INJECTION SITE PAIN 76 0.0002
958 DEPRESSED MOOD 13 0.0002
959 TINNITUS 11 0.0002
960 TREATMENT FAILURE 19 0.0002
961 DRUG INTOLERANCE 22 0.0002
962 ANGIOEDEMA 10 0.0002
963 MEMORY IMPAIRMENT 31 0.0002
964 PROSTATE CANCER 18 0.0002
965 MIGRAINE 21 0.0002
966 PRODUCT USE ISSUE 41 0.0002
967 COGNITIVE DISORDER 10 0.0002
968 HOT FLUSH 16 0.0002
969 ECZEMA 11 0.0002
970 RENAL CANCER 10 0.0002
971 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
972 TOXICITY TO VARIOUS AGENTS 35 0.0002
973 DISTURBANCE IN ATTENTION 11 0.0002
974 AGGRESSION 10 0.0002
975 ABORTION SPONTANEOUS 8 0.0002
976 PRODUCT DOSE OMISSION 13 0.0002
977 SKIN BURNING SENSATION 14 0.0002
978 NERVOUSNESS 10 0.0002
979 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
980 UNDERDOSE 13 0.0002
981 EYE PAIN 10 0.0002
982 INJECTION SITE REACTION 12 0.0002
983 BREAST CANCER 16 0.0002
984 INCORRECT DOSE ADMINISTERED 37 0.0002
985 DEVICE MALFUNCTION 11 0.0002
986 OVERDOSE 32 0.0001
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
988 PRODUCT QUALITY ISSUE 19 0.0001
989 NO ADVERSE EVENT 25 0.0001
990 INTENTIONAL PRODUCT MISUSE 12 0.0001
991 SUICIDAL IDEATION 11 0.0001
992 ACNE 9 0.0001
993 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
994 INJECTION SITE ERYTHEMA 14 0.0001
995 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
996 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
997 PRODUCT DOSE OMISSION ISSUE 20 0.0001